Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy

NCT02402231 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
23
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Caroline Nilsson